<DOC>
	<DOCNO>NCT01566760</DOCNO>
	<brief_summary>This open-label ( physician healthy volunteer know medication administer ) , single-dose , 2-cohort , 3-period study characterize pharmacokinetics ( process drug fesoterodine absorb , distribute , metabolize , eliminate body ) effect food pharmacokinetics drug . This study take place approximately 8 week consist screen visit determine eligibility study , 2- 3-period treatment phase cohort .</brief_summary>
	<brief_title>A Study To Estimate The Effects Of Food On Drug Fesoterodine Fumarate And The Pharmacokinetics Of 5-Hydroxymethyl Tolterodine ( 5-HMT ) In Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>Healthy male and/or female subject 21 55 year age ( inclusive ) . Evidence history clinically significant disease . Evidence history urologic disease ( benign prostate hyperplasia , recurrent urinary tract infection , urinary retention , etc . ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>food effect</keyword>
	<keyword>bioavailability</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>fesoterodine</keyword>
	<keyword>5-hydroxymethyl tolterodine</keyword>
	<keyword>treatment overactive bladder</keyword>
</DOC>